Good News ....maybe?Imho the announcement today should be considered neutral to positive. It is arguably neutral because (a) the sp is what it is and (b) Andrew Ryu, right or wrong, has a much more demonstrable interest in Datametrex than in ScreenPro.
It certainly has the potential to be positive because (a) the sp can only go up and (b) new outside blood in the CEO chair working with Lena could very well accelerate expansion away from covid testing only. The new director, an advisor to Datametrex has a substantial resume so he too may look at this as an opportunity to take a young company to the next level. Of course he is likely the conduit between DM and SCRN as relates to covid testing.
I certainly like the idea of a management team that has little more autonomy from DM then it did yesterday.